510(k) · Cleared
ClearedFertell Female Fertility Test
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Genosis, Inc. · NGA Test, Follicle Stimulating Hormone (Fsh), Over The Counter
Cleared on Oct 30, 2003 as substantially equivalent to K002450 (Genua 1944, Inc., 2001) and 3 other predicates after a 125-day review. Its family tree reaches back 1 generation to 1986. 1 later device descends from it.
- Decided
- Oct 30, 2003
- Review
- 125 days
- Class
- Class I
- Product code
- NGA
- Recalls
- None
- Predicates
- 6
Its longest line of descent runs back 1 generation to K862813 (1986). 4 ancestors in all. 1 later device descends from it, 1 citing it directly.
Most influential descendants
Showing 1 of 1 · See all- K070484Quantrx Female Fertility TestQuantrx Biomedical Corporation · 2007 · cites it directly0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −1 | K862813 | FSH Maiaclone Immunoradiometric Assay Kit | Serono Diagnostics, Inc. | 1986 | — |
| 0 (this device) | K032002 | Fertell Female Fertility Test | Genosis, Inc. | 2003 | — |
| +1 | K070484 | Quantrx Female Fertility Test | Quantrx Biomedical Corporation | 2007 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 2001 | 1 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2007 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in NGA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
- Candidate predicates for a device like this, rankedin the report
- Recall history across each candidate’s familyin the report
What was it cleared against? (6)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary; numbers the summary cites that cannot be its predicate are marked – and kept off the family tree.
| Type | Number | Device | Decided |
|---|---|---|---|
| Kept off the family tree | K023408 | Instacheck Menopause Predictor Test Not in FDA’s 510(k), De Novo or PMA lists as we hold them (a misreading, a typo, or a number FDA does not list), so it is kept off the family tree Summary page 1…Counter) 21 C.F.R. 5 862.1300 Legally Marketed Predicate Devices: Instacheck Menopause Predictor Test (K023408) Surestep FSH Menopause Test (K010556) Genua Menopause Monitor Test Kit (K002450) AxSYM Follicle Stimulating Hormone (K935612)… | |
| Kept off the family tree | K010556 | Surestep FSH Menopause Test Not in FDA’s 510(k), De Novo or PMA lists as we hold them (a misreading, a typo, or a number FDA does not list), so it is kept off the family tree Summary page 1…21 C.F.R. 5 862.1300 Legally Marketed Predicate Devices: Instacheck Menopause Predictor Test (K023408) Surestep FSH Menopause Test (K010556) Genua Menopause Monitor Test Kit (K002450) AxSYM Follicle Stimulating Hormone (K935612) MAIAcloneTMFSH Assay (K8628 13) FIRS… | |
| * | K002450 | Genua Menopause Monitor Test KitSummary page 1…862.1300 Legally Marketed Predicate Devices: Instacheck Menopause Predictor Test (K023408) Surestep FSH Menopause Test (K010556) Genua Menopause Monitor Test Kit (K002450) AxSYM Follicle Stimulating Hormone (K935612) MAIAcloneTMFSH Assay (K8628 13) FIRST RESPONSE Ovulation Predictor Test (K95358… | 2001 |
| * | K935612 | Axsym Follicle Stimulating Hormone (FSH)Summary page 1…Instacheck Menopause Predictor Test (K023408) Surestep FSH Menopause Test (K010556) Genua Menopause Monitor Test Kit (K002450) AxSYM Follicle Stimulating Hormone (K935612) MAIAcloneTMFSH Assay (K8628 13) FIRST RESPONSE Ovulation Predictor Test (K95358 1)… | 1994 |
| * | K862813 | FSH Maiaclone Immunoradiometric Assay KitSummary page 1…or Test (K023408) Surestep FSH Menopause Test (K010556) Genua Menopause Monitor Test Kit (K002450) AxSYM Follicle Stimulating Hormone (K935612) MAIAcloneTMFSH Assay (K8628 13) FIRST RESPONSE Ovulation Predictor Test (K95358 1)… | 1986 |
| * | K953581 | First Response Ovulation Predictor TestSummary page 1…556) Genua Menopause Monitor Test Kit (K002450) AxSYM Follicle Stimulating Hormone (K935612) MAIAcloneTMFSH Assay (K8628 13) FIRST RESPONSE Ovulation Predictor Test (K95358 1) 0020 Device Descript… | 1995 |
What descends from it? (1)
1 later device cites it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K070484 | Quantrx Female Fertility Test | 2007 | 0 |
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- 1 of the 4 ancestors has a recall of any class.
- Of its descendants, K070484 (Quantrx Biomedical Corporation, 2007) has gone furthest, with 0 descendants of its own.
How does its category compare?
All NGA devicesNGA Test, Follicle Stimulating Hormone (Fsh), Over The Counter: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · NGA
1in 2007
2026 to Oct 25, outlined.
Median 510(k) review, days · NGA
Too few NGA 510(k)s in any year since 2007 to give a median.
Recalls per year · NGA
1in 2025
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · NGA
No MAUDE report names NGA since 2007.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 1 | — | 0 | 0 |
| 2008 | 0 | — | 0 | 0 |
| 2009 | 0 | — | 0 | 0 |
| 2010 | 0 | — | 0 | 0 |
| 2011 | 0 | — | 0 | 0 |
| 2012 | 0 | — | 0 | 0 |
| 2013 | 0 | — | 0 | 0 |
| 2014 | 0 | — | 0 | 0 |
| 2015 | 0 | — | 0 | 0 |
| 2016 | 0 | — | 0 | 0 |
| 2017 | 0 | — | 0 | 0 |
| 2018 | 0 | — | 0 | 0 |
| 2019 | 0 | — | 0 | 0 |
| 2020 | 0 | — | 0 | 0 |
| 2021 | 0 | — | 0 | 0 |
| 2022 | 0 | — | 0 | 0 |
| 2023 | 0 | — | 0 | 0 |
| 2024 | 0 | — | 0 | 0 |
| 2025 | 0 | — | 1 | 0 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
The Fertell Female Fertility Test is intended to measure Follicle Stimulating Hormone (“FSH’) in urine as an adjunctive screen of fertility for home use by women who are attempting to conceive but have been unsuccessful.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K032002 · printed Nov 6, 2026
Cite this page
510(k) Report. “K032002: Fertell Female Fertility Test.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K032002
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026